Prosecution Insights
Last updated: July 17, 2026
Application No. 18/157,504

TECHNIQUES FOR REMOVING SCATTER FROM CBCT PROJECTIONS

Non-Final OA §103
Filed
Jan 20, 2023
Examiner
DARDANO, STEFANO ANTHONY
Art Unit
2663
Tech Center
2600 — Communications
Assignee
Elekta Ltd.
OA Round
3 (Non-Final)
78%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 78% — above average
78%
Career Allowance Rate
66 granted / 85 resolved
+15.6% vs TC avg
Strong +34% interview lift
Without
With
+34.0%
Interview Lift
resolved cases with interview
Typical timeline
2y 12m
Avg Prosecution
13 currently pending
Career history
100
Total Applications
across all art units

Statute-Specific Performance

§101
2.2%
-37.8% vs TC avg
§103
88.9%
+48.9% vs TC avg
§102
3.3%
-36.7% vs TC avg
§112
5.6%
-34.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 85 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Status A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 03/03/26 has been entered. Claims 1, 7, 11, 21, 26, and 31 have been amended, claim 6 has been canceled. Claim 1-5, and 7-31 are pending. This application has undergone a restriction, claims 4-5, 14-19, 24-25, and 28-30 have been withdrawn from consideration. Response to arguments On pages 11-12 of the remarks, applicant asserts: A person of ordinary skill in the art would not find this approach to be disclosed or suggested by Hua. As previously discussed by Applicant in the response filed November 10, 2025, Hua is directed to various techniques to generate simulated noise or scatter data to add to its simulated CBCT projection dataset. At most, Hua discusses adding noise or scatter data from different angles in an effort to produce its simulated data set, in paragraph [0022], based on Monte Carlo simulations. Hua does not discuss generating multiple (i.e., a plurality of) variation images from a same projection viewpoint as claimed. Hua also does not discuss any relevant technique to provide variation of these images among each other, by transforming the variation images from simulated deformations that provide variation of at least one target tumor or target organ as depicted from the same projection viewpoint. The examiner respectfully disagrees, Hua discusses generating training data from a plurality of viewpoints ([0022]: “For each volume, numerous sets (e.g., 50-300) of various-angle data can be simulated”), and Hua also discusses augmenting the training data to generate different kinds of training data from a same perspective ([0024]: “In order to increase an amount of data available for training, an initial training set is augmented/enlarged by at least one of interpolating between views and rotating pieces of data to produce additional training data”). The initial training set would be the 50-300 various angle data that can be simulated, and that initial training data can be augmented via interpolation between views and rotation, this augmentations would allow for a plurality of variation images from the same viewpoint. Further down pages 10-11, applicant asserts: Hua does not disclose any techniques that would produce simulated deformations of a tumor or target organ. Rather, Hua discusses different techniques involving truncation (e.g., in paragraph [0043]), which, as is commonly understood in the art, causes artifacts in attenuation and distorted contrast often at the edge of an image. Truncation occurs when some anatomical object lies outside the scanner's field of view and is not fully captured. Truncation of an anatomical object from an image is different than deformation of an anatomical object in an image, because when truncation occurs, the anatomical object itself is not represented by a full set of data. The claimed technique of"deformations that provide variation of at least one target tumor or target organ as depicted from the same projection viewpoint" cannot occur in real-world or simulated truncated data. The examiner agrees with part of the assertion, while truncation can cause deformation of the image edges, it is not with respect to using deformation as an additional augmentation of original training data, and using both original and augmented training data for training the model. Another piece of art will be applied for this deformation and dual training data aspect. Further in the remarks, applicant continues: Further, in paragraphs [0043]-[0052], Hua appears to discuss truncation correction and scatter correction with the use of separate neural networks. Paragraph [0064] of Hua also discusses the separate application of truncation and scatter correction techniques even within one neural network. A person of ordinary skill in the art would not understand Hua as simulating truncation as part of training a neural network for performing scatter correction operations. The examiner respectfully disagrees, Hua contains an embodiment where one neural network is capable of both scatter correction and truncation correction ([0082]: “In another embodiment of step 1101, the one or more neural networks is one. When there is one neural network, the one neural network is trained for saturation correction, truncation correction, and scatter correction”). So Hua is capable of having one neural network perform both scatter correction and truncation correction, which would include simulating both types of data. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-3, 7-8, 11-13, 21-23, 26-27, and 31 are rejected under 35 U.S.C. 103 as being unpatentable over HUA et al. (US 20230274473 A1 Hereinafter “HUA”) in view of EWALD et al. (US 20220415021 A1 Hereinafter “EWALD”). Regarding claim 1, HUA teaches a computer-implemented method for training a regression model for cone- beam computed tomography (CBCT) data processing, the method comprising: obtaining a reference medical image of an anatomical area of a human patient (Fig. 5, [0047]: “First, 3D volume data 409 is obtained. The 3D volume data 409 can be acquired from phantoms and/or clinical sites. For example, the 3D volume data 409 can be clinical head data or abdomen data”); generating a set of CBCT projections, the set of CBCT projections generated from the reference medical image at each of a plurality of projection viewpoints in a CBCT projection space (Fig. 5, [0048]: “Step 411 is to simulate a CBCT projection data using the 3D volume data 409 to generate a simulated CBCT projection dataset 413”. This generated data can be obtained at a plurality of viewpoints, [0022]: “For each volume, numerous sets (e.g., 50-300) of various-angle data can be simulated”); wherein generating the set of CBCT projections comprises: generating, from the reference medical image, a plurality of variation images, for each of the plurality of projection viewpoints ([0022]: “For each volume, numerous sets (e.g., 50-300) of various-angle data can be simulated” This can include multiple data in the same angle/viewpoint); and transforming the plurality of variation images to provide variation among each other from a same projection viewpoint in the CBCT projection space ([0024]: “In order to increase an amount of data available for training, an initial training set is augmented/enlarged by at least one of interpolating between views and rotating pieces of data to produce additional training data”. These interpolations and rotations of data would augment the medical data to provide variation among each other from a same perspective viewpoint. For example, viewpoint 1 can have 2 images, viewpoint 2 also has 2 images, viewpoint 2’s image is interpolated to viewpoint 1 and rotated, this would provide viewpoint 1 with another image from the viewpoint which varies from the current images in viewpoint 1); wherein the plurality of variation images include simulated ([0024]: “In order to increase an amount of data available for training, an initial training set is augmented/enlarged by at least one of interpolating between views and rotating pieces of data to produce additional training data”. These interpolations and rotations of data would augment the medical data to provide variation among each other from a same perspective viewpoint. This would provide variation to the target organ depicted from the same projection viewpoint); generating a set of simulated scatter data, the set of simulated scatter data to represent effects of scatter from CBCT imaging in each respective projection in the set of CBCT projections (Fig. 5, [0049]: “Step 415 is to simulate a CBCT scatter dataset using the 3D volume data 409 to generate a simulated CBCT scatter dataset 417. The simulated CBCT scatter dataset 417 indicates a scatter profile from the 3D volume data 409, and can be generated using Monte Carlo techniques (e.g. GEANT4) and/or radiative transfer equation (RTE) techniques”); and training the regression model using the set of CBCT projections and the set of simulated scatter data ([0050]: “In step 423, a neural network is trained using the simulated CBCT projection dataset 413 as input learning data, and the smooth simulated CBCT scatter dataset 421 as target learning data”. Neural network acts as the regression model). HUA does not expressly disclose the augments to the image data being deformation of the data to provide variation in image training data of a same perspective. However, EWALD teaches augmenting medical image data using deformation of the training data to provide variation in image training data ([0100]: “In particular, by using the invention, an additional set of pseudo ground truth data (i.e. annotated augmented/synthetic data elements) is generated. Using the original data set plus the augmented data for a later network training will make the final machine-learning model (trained using such data) more robust or, (if, for instance, there are only a limited number few initially available data sets) even feasible”. This augmented/synthetic training data is obtained by deforming the obtained medical data “In some embodiments, the anatomical model is deformable according to a plurality of deformation techniques, and the step of deforming the anatomical model comprises deforming the anatomical model using a subset of the plurality of deformation techniques. The step of generating the one or more annotated augmented data elements may comprises: generating one or more augmented data elements using the deformed anatomical model” [0023-0024]). At the time the invention was effectively filed, it would have been obvious to one of ordinary skill in the art to modify HUA’s training data to include EWALD’s deformation of medical data for additional training data because such a modification is taught, suggested, or motivated by the art. More specifically, the motivation to modify HUA to include EWALD is expressly provided by EWALD, stating that using augmented training data alongside original training data for training a model improves the robustness of the model ([0100]: “In particular, by using the invention, an additional set of pseudo ground truth data (i.e. annotated augmented/synthetic data elements) is generated. Using the original data set plus the augmented data for a later network training will make the final machine-learning model (trained using such data) more robust or, (if, for instance, there are only a limited number few initially available data sets) even feasible”. Therefore, it would have been obvious to one of ordinary skill in the art at the time of the invention to modify HUA’s training data to include EWALD’s deformation of medical data for additional training data with the motivation of improving model robustness. The person of ordinary skill in the art would have recognized the benefit of a more robust model. Regarding claim 2, the combination of HUA and EWALD teaches the method of claim 1, in addition, HUA further teaches wherein the trained regression model is configured to infer scatter from newly captured CBCT projections (Fig. 5, [0050]: “The output of step 423 is a scatter estimation neural network 403, which can estimate the scatter profile of a projection dataset input”), and wherein training the regression model includes training with pairs of generated simulated scatter data that represents simulated scatter and generated CBCT projections that include effects based on the simulated scatter (Fig. 5, [0050]: “In step 423, a neural network is trained using the simulated CBCT projection dataset 413 as input learning data, and the smooth simulated CBCT scatter dataset 421 as target learning data”. These training pairs include data that represents the simulated scatter (smooth simulated CBCT scatter dataset) and the generated CBCT projections that include effects based on the simulated scatter (simulated CBCT projection dataset 413 that contains the scatter effects). Regarding claim 3, the combination of HUA and EWALD teaches the method of claim 2, in addition, HUA further teaches wherein the trained regression model is configured to receive a newly captured CBCT projection that includes effects from scatter as input (Fig. 5, [0050]: “The output of step 423 is a scatter estimation neural network 403, which can estimate the scatter profile of a projection dataset input”. These projection dataset inputs contain effects from scatter), and wherein the trained regression model is configured to provide an identification of the effects from the scatter as output (Fig. 5, [0050]: “The output of step 423 is a scatter estimation neural network 403, which can estimate the scatter profile of a projection dataset input”. These projection dataset inputs contain effects from scatter). Regarding claim 7, the combination of HUA and EWALD teaches the method of claim 1, in addition, HUA further teaches wherein the plurality of variation images are generated by geometrical augmentations or geometric changes to representations of the anatomical area obtained from the reference medical image ([0024]: “In order to increase an amount of data available for training, an initial training set is augmented/enlarged by at least one of interpolating between views and rotating pieces of data to produce additional training data”. These interpolations and rotations of data would be considered geometric changes, and they would affect the representations of the anatomical area obtained from the reference medical image), and wherein the plurality of projection viewpoints correspond to a plurality of projection angles used for capturing CBCT projections ([0022]: “For each volume, numerous sets (e.g., 50-300) of various-angle data can be simulated”. This differing angle data is the plurality of projection angles for the plurality of projection viewpoints). Regarding claim 8, the combination of HUA and EWALD teaches the method of claim 1, in addition, HUA further teaches, wherein the reference medical image is a 3D image provided from a computed tomography (CT) scan ([0039]: “Alternatively, a high resolution CT dataset may be created by simulating a digital phantom that is converted to 3D volume data that can be processed as if it were acquired 3D data”. The 3D volume data can act as a high resolution CT dataset), and wherein the method further comprises training of the regression model using a plurality of reference medical images from the CT scan (Fig. 5, [0047]: “First, 3D volume data 409 is obtained. The 3D volume data 409 can be acquired from phantoms and/or clinical sites. For example, the 3D volume data 409 can be clinical head data or abdomen data. This 3D volume data 409 can be used to generate synthetic pairs of projection and scatter datasets for training”. There can be a plurality of reference images (3D volume data), [0021]: “In one embodiment, numerous sets of different 3D/volume data 120 can be acquired from phantoms and clinical sites and can be used to generate the synthetic pair of projection images and scatter images”). Regarding claim 11, HUA teaches a computer-implemented method for using a trained regression model for cone-beam computed tomography (CBCT) data processing, the method comprising: accessing a trained regression model configured for processing CBCT projection data, wherein the trained regression model is trained using corresponding sets of simulated scatter data and CBCT projections ([0050]: “In step 423, a neural network is trained using the simulated CBCT projection dataset 413 as input learning data, and the smooth simulated CBCT scatter dataset 421 as target learning data”), wherein the CBCT projections used in training are produced from at least one reference medical image at respective projection viewpoints of an anatomical region in a CBCT projection space (Fig. 5, [0048]: “Step 411 is to simulate a CBCT projection data using the 3D volume data 409 to generate a simulated CBCT projection dataset 413”. This generated data can be obtained at a plurality of viewpoints, [0022]: “For each volume, numerous sets (e.g., 50-300) of various-angle data can be simulated”. This data is also of anatomical regions “For example, the 3D volume data 409 can be clinical head data or abdomen data” ([0047])), wherein the CBCT projections used in training include a plurality of variation images, generated from the at least one reference medical image, which include simulated that provide variation of at least one target tumor or target organ as depicted from a same projection viewpoint in the CBCT projection space ([0024]: “In order to increase an amount of data available for training, an initial training set is augmented/enlarged by at least one of interpolating between views and rotating pieces of data to produce additional training data”. These interpolations and rotations of data would augment the medical data to provide variation among each other from a same perspective viewpoint. This would provide variation to the target organ depicted from the same projection viewpoint), and wherein the simulated scatter data used in training represents respective effects of scatter from CBCT imaging in the CBCT projections (Fig. 5, [0049]: “Step 415 is to simulate a CBCT scatter dataset using the 3D volume data 409 to generate a simulated CBCT scatter dataset 417. The simulated CBCT scatter dataset 417 indicates a scatter profile from the 3D volume data 409, and can be generated using Monte Carlo techniques (e.g. GEANT4) and/or radiative transfer equation (RTE) techniques”); providing a newly captured CBCT projection as an input to the trained regression model, wherein the newly captured CBCT projection includes effects from scatter (Fig. 5, [0050]: “The output of step 423 is a scatter estimation neural network 403, which can estimate the scatter profile of a projection dataset input”. The projection dataset input is a newly captured CBCT projection which includes the effects from scatter); and obtaining data as an output of the trained regression model, wherein the data is based on identified effects from scatter (Fig. 5, [0050]: “The output of step 423 is a scatter estimation neural network 403, which can estimate the scatter profile of a projection dataset input”. The output is the scatter profile of the projection dataset, which contains the identified effects from scatter). HUA does not expressly disclose the augments to the image data being deformation of the data to provide variation in image training data of a same perspective. However, EWALD teaches augmenting medical image data using deformation of the training data to provide variation in image training data ([0100]: “In particular, by using the invention, an additional set of pseudo ground truth data (i.e. annotated augmented/synthetic data elements) is generated. Using the original data set plus the augmented data for a later network training will make the final machine-learning model (trained using such data) more robust or, (if, for instance, there are only a limited number few initially available data sets) even feasible”. This augmented/synthetic training data is obtained by deforming the obtained medical data “In some embodiments, the anatomical model is deformable according to a plurality of deformation techniques, and the step of deforming the anatomical model comprises deforming the anatomical model using a subset of the plurality of deformation techniques. The step of generating the one or more annotated augmented data elements may comprises: generating one or more augmented data elements using the deformed anatomical model” [0023-0024]). At the time the invention was effectively filed, it would have been obvious to one of ordinary skill in the art to modify HUA’s training data to include EWALD’s deformation of medical data for additional training data because such a modification is taught, suggested, or motivated by the art. More specifically, the motivation to modify HUA to include EWALD is expressly provided by EWALD, stating that using augmented training data alongside original training data for training a model improves the robustness of the model ([0100]: “In particular, by using the invention, an additional set of pseudo ground truth data (i.e. annotated augmented/synthetic data elements) is generated. Using the original data set plus the augmented data for a later network training will make the final machine-learning model (trained using such data) more robust or, (if, for instance, there are only a limited number few initially available data sets) even feasible”. Therefore, it would have been obvious to one of ordinary skill in the art at the time of the invention to modify HUA’s training data to include EWALD’s deformation of medical data for additional training data with the motivation of improving model robustness. The person of ordinary skill in the art would have recognized the benefit of a more robust model. Regarding claim 12, the combination of HUA and EWALD teaches the method of claim 11, in addition, HUA further teaches wherein the trained regression model is configured to infer scatter from the newly captured CBCT projection (Fig. 5, [0050]: “The output of step 423 is a scatter estimation neural network 403, which can estimate the scatter profile of a projection dataset input”. The projection dataset input is a newly captured CBCT projection which includes the effects from scatter), and wherein the data generated by the trained regression model comprises scatter data that represents the identified effects from scatter (Fig. 5, [0050]: “The output of step 423 is a scatter estimation neural network 403, which can estimate the scatter profile of a projection dataset input”. The output is the scatter profile of the projection dataset, which contains the identified effects from scatter).. Regarding claim 13, the combination of HUA and EWALD teaches the method of claim 12, in addition, HUA further teaches wherein the trained regression model is trained with pairs of simulated scatter data that represents simulated scatter and generated CBCT projections that include effects based on the simulated scatter (Fig. 5, [0050]: “In step 423, a neural network is trained using the simulated CBCT projection dataset 413 as input learning data, and the smooth simulated CBCT scatter dataset 421 as target learning data”. These training pairs include data that represents the simulated scatter (smooth simulated CBCT scatter dataset) and the generated CBCT projections that include effects based on the simulated scatter (simulated CBCT projection dataset 413 that contains the scatter effects). Regarding claim 21, the content of claim 21 is similar to the content of claim 1, with the additional teachings of a non-transitory computer-readable storage medium. HUA also discloses this information ([0106]: “Alternatively, the CPU in the reconstruction device 514 can execute a computer program including a set of computer-readable instructions that perform the functions described herein, the program being stored in any of the above-described non-transitory electronic memories and/or a hard disk drive, CD, DVD, FLASH drive or any other known storage media”). Therefore, claim 21 is rejected for the same reasons of obviousness as claim 1, along with the additional teachings above. Regarding claim 22, the content of claim 22 is similar to the content of claim 2, therefore it is rejected for the same reasons of obviousness as claim 2. Regarding claim 23, the content of claim 23 is similar to the content of claim 3, therefore it is rejected for the same reasons of obviousness as claim 3. Regarding claim 26, the content of claim 26 is similar to the content of claim 11, therefore it is rejected for the same reasons of obviousness as claim 11. Regarding claim 27, the content of claim 27 is similar to the content of claim 12, therefore it is rejected for the same reasons of obviousness as claim 12. Regarding claim 31, the content of claim 31 is similar to the content of claim 7, therefore it is rejected for the same reasons of obviousness as claim 7. Claims 9-10 and 20 rejected under 35 U.S.C. 103 as being unpatentable over HUA et al. (US 20230274473 A1 Hereinafter “HUA”) in view of EWALD et al. (US 20220415021 A1 Hereinafter “EWALD”) in further view of Xu et al. (US 20200151922 A1 Hereinafter “Xu”). Regarding claim 9, the combination of HUA and EWALD teaches the method of claim 1, The combination of HUA and EWALD does not expressly disclose wherein the trained regression model is used for radiotherapy treatment of the human patient, and wherein the anatomical area corresponds to an area of the radiotherapy treatment. However, Xu teaches wherein a trained regression model is used for radiotherapy treatment of the human patient, and wherein the anatomical area corresponds to an area of the radiotherapy treatment (Fig. 1, [0034]: “FIG. 1 illustrates an exemplary radiotherapy system 10 for providing radiation therapy to a patient. The radiotherapy system 10 includes an image processing device, 12”. This Radiotherapy system uses a trained Deep Convolutional Neural network to remove scatter, [0084]: “FIG. 9C illustrates a method for generating artifact reduced, reconstructed 3D images using a trained DCNN, such as a DCNN that can be trained according to the method described above with respect to FIG. 9B. The DCNN can reduce artifacts such as noise, scatter, extinction artifacts, beam hardening artifacts, exponential edge gradient effects, aliasing effects, ring artifacts, motion artifacts, or misalignment effects”). At the time the invention was made, it would have been obvious to one of ordinary skill in the art to modify the combination of HUA and EWALD’s scatter correction system for improved CBCT images to include Xu’s use of the improved CBCT images in Radiotherapy because such a modification is based on the use of known techniques to improve similar devices in the same way. More specifically, Xu’s CBCT scatter correction is comparable to the combination of HUA and EWALD’s scatter correction system for improved CBCT images because they both are systems meant to reduce the scatter in CBCT images using trained models. Therefore, it would be obvious to one of ordinary skill in the art to modify the combination of HUA and EWALD’s scatter correction system for improved CBCT images to include Xu’s use of the improved CBCT images in Radiotherapy in order to obtain the predictable result of using the combination of HUA and EWALD’s image improving process to aid in radiotherapy Regarding claim 10, the combination of HUA, EWALD, and Xu teaches the method of claim 9, in addition, Xu further teaches wherein the method further includes training of the regression model using a plurality of reference medical images from one or more prior computed tomography (CT) scans or one or more prior CBCT scans of the human patient ([0038]: “Patient data 45 may include information such as (1) functional organ modeling data (e.g., serial versus parallel organs, appropriate dose response models, etc.); (2) radiation dosage data (e.g., dose-volume histogram (DVH) information; or (3) other clinical information about the patient and course of treatment (e.g., other surgeries, chemotherapy, previous radiotherapy, etc.)”. Previous reference medical images would be encompassed in the previous radiotherapy of the same method (Emphasis added)). At the time the invention was made, it would have been obvious to one of ordinary skill in the art to modify the combination of HUA, EWALD, and Xu’s CBCT scatter correction system to include Xu’s use of prior patient data for training because such a modification is the result of applying a known technique to a known device ready for improvement to yield predictable results. More specifically, Xu’s use of prior patient data for training permits training a model using data associated with the patient, improving the diversity of training data for the model. This known benefit in Xu is applicable to the combination of HUA, EWALD, and Xu’s CBCT scatter correction system as they both share characteristics and capabilities, namely, they are directed to scatter correction for CBCT data. Therefore, it would have been recognized that modifying the combination of HUA, EWALD, and Xu’s CBCT scatter correction system to include Xu’s use of prior patient data for training would have yielded predictable results because (i) the level of ordinary skill in the art demonstrated by the references applied shows the ability to incorporate Xu’s use of prior patient data for training in scatter correction for CBCT data and (ii) the benefits of such a combination would have been recognized by those of ordinary skill in the art. Regarding claim 20, the combination of HUA and EWALD teaches the method of claim 11, The combination of HUA and EWALD does not expressly wherein the at least one reference medical image comprises multiple images captured from one or more prior computed tomography (CT) scans or one or more prior CBCT scans of a human patient. However, Xu teaches wherein the at least one reference medical image comprises multiple images captured from one or more prior computed tomography (CT) scans or one or more prior CBCT scans of a human patient ([0038]: “Patient data 45 may include information such as (1) functional organ modeling data (e.g., serial versus parallel organs, appropriate dose response models, etc.); (2) radiation dosage data (e.g., dose-volume histogram (DVH) information; or (3) other clinical information about the patient and course of treatment (e.g., other surgeries, chemotherapy, previous radiotherapy, etc.)”. Previous reference medical images would be encompassed in the previous radiotherapy of the same method (Emphasis added)). The rationale for the combination of claim 20 is similar to the rationale for the combination of claim 10, due to similar methods of combination and benefits. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure: YANG et al. (CN 108389242 A) teaches a method of scatter correction. Any inquiry concerning this communication or earlier communications from the examiner should be directed to STEFANO A DARDANO whose telephone number is (703)756-4543. The examiner can normally be reached Monday - Friday 11:00 - 7:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Greg Morse can be reached on (571) 272-3838. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /STEFANO ANTHONY DARDANO/ Examiner, Art Unit 2663 /GREGORY A MORSE/Supervisory Patent Examiner, Art Unit 2698
Read full office action

Prosecution Timeline

Show 2 earlier events
Nov 10, 2025
Response Filed
Dec 11, 2025
Final Rejection mailed — §103
Jan 26, 2026
Interview Requested
Feb 04, 2026
Applicant Interview (Telephonic)
Feb 04, 2026
Examiner Interview Summary
Mar 03, 2026
Request for Continued Examination
Mar 05, 2026
Response after Non-Final Action
May 08, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12670621
METHOD AND SYSTEM FOR TRACKING A STATE OF A CAMERA
3y 0m to grant Granted Jun 30, 2026
Patent 12670619
EYE TRACKING
2y 8m to grant Granted Jun 30, 2026
Patent 12657689
SUBSTRATE DEFECT-DETECTION AND COMPARISON
2y 10m to grant Granted Jun 16, 2026
Patent 12651351
INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND PROGRAM
3y 9m to grant Granted Jun 09, 2026
Patent 12639809
QUALITY ASSURANCE WORKFLOWS FOR LOW-FIELD MRI PROSTATE DIAGNOSTIC SYSTEMS
3y 5m to grant Granted May 26, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
78%
Grant Probability
99%
With Interview (+34.0%)
2y 12m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 85 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month